Categories: News Features

BD Expands Efforts to Combat Antimicrobial Resistance in India with New Automated ID/AST System

Launches new BD Phoenix™ M50 System at MicroCon 2016 that delivers modularity, reliability, affordability and high-quality susceptibility results needed by clinical microbiology laboratories

New Delhi, December 10, 2016: BD (Becton, Dickinson and Company), a leading global medical technology company, announced the launch of its next generation diagnostic instrument for the rapid identification of bacteria and detection of antimicrobial resistance (AMR).

The new BD Phoenix™ M50 ID/AST system helps deliver the same rapid, accurate and cost-effective testing as the legacy BD Phoenix™ 100, within a smaller footprint. The system is highly reliable and requires no preventative maintenance, thanks to innovative materials and engineering techniques employed during its development.

“The health care community is facing unprecedented challenges with the spread of multidrug resistant organisms, and today’s clinical microbiology laboratories are under increasing pressure to provide fast and accurate bacterial identification and antimicrobial susceptibility testing(ID/AST) results to influence clinical decision and outcomes.TheBD Phoenix M50 system is an attractive solution for microbiology laboratories in Indiaand intensifies our support to the fight against antimicrobial resistance,” said Noel Wentworth, Business Director of Diagnostics Systems for BD in Central and South Asia.

Neeraj Raghuvanshi, Business Director of Diagnostics Systems for BD in India added, “Over-the-counter access to antibiotics is a problem.Improvements in clinical and laboratory practices, combined with effective deployment and use of medical technology, can help to ensure antimicrobials are utilized appropriately, reducing risk to patients and lowering costs associated with resistance. Antimicrobial resistance is a threat that can be solved with a collective effort and with the launch of our technology we want to play an active role in this public health challenge.”

About BD Phoenix M50 system:

The new system benefits from the demonstrated performance of the legacy BD Phoenix 100 system for detecting current and emerging resistances as well as the extended testing capabilities provided by BD Phoenix™ Emerge AST panel with 136 wells.

The BD Phoenix M50 system also offers integration with multiple other analyzers, including the BD BACTEC™ and BD Bruker™MALDIBiotyper systems, through BD EpiCenter™ middleware connectivity that enables data traceability and security, paperless workflow and flexible communication capabilities to deliver the efficiencies expected by laboratories of all sizes. The BD Phoenix M50 system joins the overall BD diagnostics portfolio to help drive the transformation of microbiology.

Visit bd.com/ds for more information.

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Kaivalyadhama to Host 11th International Conference on Yoga in Cancer Care, Uniting Global Experts to Explore Yoga’s Role in Holistic Cancer Support

Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…

7 hours ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

7 hours ago

From Pain to Relief: How endoscopic spine surgery enhances patient outcomes

By DR UMESH SRIKANTHA, Senior Consultant - Neurosurgery, Head of Spine Services, Aster RV Hospital …

1 day ago

Henkel India Unveils Dedicated Researchers’ World Lab in India

Pune, November 11, 2024: Henkel Adhesives Technologies India Private Limited (Henkel India) announces the opening…

1 day ago

Esaote Group Expands Production in India

Noida, November 08, 2024: Esaote Group, a leading Italian innovator in medical imaging - ultrasound,…

4 days ago

In Q2 FY25, AGI Greenpac Limited posts EBITDA of ₹166 crore up by 20% Y-o-Y and PAT of Rs ₹72 crore up by 28%

Gurugram, November 08, 2024: AGI Greenpac Limited, a focused Packaging Products company, today announced its financial…

4 days ago